Clinical trial
Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease. A Prospective Follow-up of 4,935 Person-years
NCT01241227 is registered in ClinicalTrials.gov with Association HGE CHU Bordeaux Sud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease. A Prospective Follow-up of 4,935 Person-years
- Lead sponsor
- Association HGE CHU Bordeaux Sud
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2003
- Completion date
- February 28, 2009
- Enrollment
- 1,830 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver fibrosis